Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Crucially for the 20262031 forecast period, Teva's generic manufacturing infrastructure which includes peptide synthesis capabilities positions it as a potential major player in the semaglutide and tirzepatide generic market that will open following patent expiries (semaglutide: US patent 2032
Its not something new: it was introduced around 1950 and today it can be used up to 1% worldwide
2010: Novo Nordisk suspende desarrollo clnico por razones estratgicas (no por problemas de seguridad)
doi:10.1016/j.numecd.2023.03.023
)
US$ 28.55
US$ 23.47
)
US$ 27.38
)
US$ 27.93
US$ 21.57
